Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 35951 - 35975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Doxorubicin	Approved Investigational	KAT2B	8850	upregulated	Doxorubicin results in increased expression of KAT2B mRNA	3p24.3	A21894
Doxorubicin	Approved Investigational	KCNH2	3757	downregulated	Doxorubicin results in decreased expression of KCNH2 mRNA	7q36.1	A21904
Doxorubicin	Approved Investigational	KCNJ13	3769	downregulated	Doxorubicin results in decreased expression of KCNJ13 mRNA	2q37.1	A22426
Doxorubicin	Approved Investigational	KCNJ16	3773	downregulated	Doxorubicin results in decreased expression of KCNJ16 mRNA	17q24.3	A22426
Doxorubicin	Approved Investigational	KCNJ2	3759	upregulated	Doxorubicin results in increased expression of KCNJ2 mRNA	17q24.3	A21904
Doxorubicin	Approved Investigational	KCNQ1	3784	downregulated	Doxorubicin results in decreased expression of KCNQ1 mRNA	11p15.5-p15.4	A21904
Doxorubicin	Approved Investigational	KHSRP	8570	upregulated	Doxorubicin results in increased expression of KHSRP mRNA	19p13.3	A22426
Doxorubicin	Approved Investigational	KLF2	10365	upregulated	Doxorubicin results in increased expression of KLF2 mRNA	19p13.11	A22419
Doxorubicin	Approved Investigational	KLF6	1316	downregulated	Doxorubicin results in decreased expression of KLF6 mRNA	10p15.2	A22430
Doxorubicin	Approved Investigational	LDB3	11155	downregulated	Doxorubicin results in decreased expression of LDB3 mRNA	10q23.2	A21904
Doxorubicin	Approved Investigational	LMNB1	4001	downregulated	Doxorubicin results in decreased expression of LMNB1 mRNA	5q23.2	A21894
Doxorubicin	Approved Investigational	LOX	4015	downregulated	Doxorubicin results in decreased expression of LOX mRNA	5q23.1	A22447
Doxorubicin	Approved Investigational	LOXL2	4017	downregulated	Doxorubicin results in decreased expression of LOXL2 mRNA	8p21.3	A22447
Doxorubicin	Approved Investigational	LOXL4	84171	downregulated	Doxorubicin results in decreased expression of LOXL4 mRNA	10q24.2	A22447
Doxorubicin	Approved Investigational	LRPAP1	4043	upregulated	Doxorubicin results in increased expression of LRPAP1 mRNA	4p16.3	A22456
Doxorubicin	Approved Investigational	LY75	4065	downregulated	Doxorubicin results in decreased expression of LY75 mRNA	2q24.2	A22426
Doxorubicin	Approved Investigational	MAP2K4	6416	upregulated	Doxorubicin results in increased expression of MAP2K4 mRNA	17p12	A21894
Doxorubicin	Approved Investigational	MAPK1	5594	downregulated	Doxorubicin results in decreased expression of MAPK1 mRNA	22q11.22	A20449
Doxorubicin	Approved Investigational	MAPK1	5594	upregulated	Doxorubicin results in increased expression of MAPK1 mRNA	22q11.22	A21894
Doxorubicin	Approved Investigational	MDM2	4193	upregulated	Doxorubicin results in increased expression of MDM2 mRNA	12q15	A22466
Doxorubicin	Approved Investigational	MEF2A	4205	upregulated	Doxorubicin results in increased expression of MEF2A mRNA	15q26.3	A21894
Doxorubicin	Approved Investigational	MEN1	4221	downregulated	Doxorubicin results in decreased expression of MEN1 mRNA	11q13	A22467
Doxorubicin	Approved Investigational	METAP2	10988	downregulated	Doxorubicin results in decreased expression of METAP2 mRNA	12q22	A22426
Doxorubicin	Approved Investigational	MFGE8	4240	upregulated	Doxorubicin results in increased expression of MFGE8 mRNA	15q26.1	A22426
Doxorubicin	Approved Investigational	MIR103A2	406896	downregulated	Doxorubicin results in decreased expression of MIR103A2 mRNA	20p13	A22468

Displaying entries 35951 - 35975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability